General Information of Drug (ID: DMDPJWF)

Drug Name
CU201 (B9870) Drug Info
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
TTD Drug ID
DMDPJWF

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug(s) Targeting Kininogen (KNG1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Avoralstat DM5YHU2 Hereditary angioedema 4A00.14 Phase 2/3 [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Kininogen (KNG1) TTDJ4MY KNG1_HUMAN Inhibitor [1]

References

1 Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents. Clin Cancer Res. 2002 May;8(5):1280-7.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)